Emma Welch, PA
Medical · Norman, OKNPI 1811591688
Payments from drug & device makers
Across 51 payments — averaging $18.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$188
- GRT US Holding, Inc.$118
- Radius Health, Inc.$85
- Sumitomo Pharma America, Inc.$70
- GSK$67
- Amgen$63
- plus $337 from 11 others
What the payments were for
- Food & beverage$928100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 13 | $188 |
| GRT US Holding, Inc. | 8 | $118 |
| Radius Health, Inc. | 4 | $85 |
| Sumitomo Pharma America, Inc. | 3 | $70 |
| GSK | 3 | $67 |
| Amgen | 4 | $63 |
| Boehringer Ingelheim | 3 | $62 |
| Forte Bio-pharma LLC | 1 | $49 |
| Sanofi Pasteur Inc. | 2 | $38 |
| Alk-abello, Inc | 2 | $35 |
| Vanda Pharmaceuticals Inc. | 2 | $31 |
| Boston Scientific | 1 | $25 |
| AbbVie | 1 | $25 |
| Lilly USA, LLC | 1 | $20 |
| Medtronic | 1 | $19 |
| Halozyme Inc | 1 | $16 |
| Exact Sciences | 1 | $15 |
How this compares
$928 in reported general payments places this provider in the 65th percentile of 370 medical providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 43 | $749 |
| Gabapentin | 35 | $648 |
| Lisinopril | 40 | $501 |
| Omeprazole | 19 | $500 |
| Atorvastatin Calcium | 39 | $495 |
| Levothyroxine Sodium | 49 | $450 |
| Famotidine | 14 | $445 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 42 | $360 |
| Amlodipine Besylate | 41 | $323 |
| Pantoprazole Sodium | 24 | $306 |
| Metoprolol Succinate | 23 | $299 |
| Montelukast Sodium | 25 | $289 |
| Ondansetron OdtOndansetron | 13 | $265 |
| Losartan Potassium | 34 | $242 |
| Methylprednisolone | 27 | $235 |
Paid to pharmacies, not to this prescriber.
Other medical in Norman
- Clint HowellNorman$10K
- Megan HutchersonNorman$7K
- Madison KearneyNorman$6K
- Mebin ThomasOklahoma City$323K
- Kelle ChristiansonMidwest City$117K
- Kristine MurrowOklahoma City$81K
- Matthew DohlmanTulsa$39K
- Katelyn PuryearOklahoma City$22K
- Tara LinvilleTulsa$19K
- Debra OdomTulsa$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.